Denali Therapeutics Inc. Liquidation Value
DNLI
Other
Cash & Equivalents
$205.33M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $205.33M
Total Obligations: -$140.64M
$64.69M
Per share: $0.41
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $205.33M
AR: $0
Total Obligations: -$140.64M
$64.69M
Per share: $0.41
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $205.33M
AR: $0
Inventory: $0
Total Obligations: -$140.64M
$64.69M
Per share: $0.41
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $64.69M | $0.41 |
| Liquid Liquidation Value | $64.69M | $0.41 |
| Operating Liquidation Value | $64.69M | $0.41 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $205.33M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $98.35M |
| Long-term Debt | N/A |
| Op. Lease Liability | $36.67M |
| Finance Lease | $5.62M |
| Shares Outstanding | 156.2M |
Explore all 204 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $205.33M | N/A | N/A | $3.33M | $98.35M | N/A | $36.67M | $5.62M |
| 2025-09-30 | $90.96M | N/A | N/A | $6.75M | $90.15M | N/A | $38.85M | $5.55M |
| 2025-06-30 | $141.21M | N/A | N/A | $10.84M | $91.06M | N/A | $40.98M | $6.99M |
| 2025-03-31 | $56.95M | N/A | N/A | $8.46M | $91.88M | N/A | $43.03M | $8.54M |
| 2024-12-31 | $174.96M | N/A | N/A | $11.14M | $102.21M | N/A | $44.98M | $9.34M |
| 2024-09-30 | $90.64M | N/A | N/A | $9.59M | $87.09M | N/A | $46.89M | $5.63M |
| 2024-06-30 | $74.68M | N/A | N/A | $13.94M | $74.53M | N/A | $48.75M | N/A |
| 2024-03-31 | $60.57M | N/A | N/A | $11.86M | $82.58M | N/A | $50.55M | N/A |
▼ Community Notes